West Pharma rises after raising annual forecasts

West Pharmaceutical Services

23/07/2026 12:13

** Shares of medical equipment maker West Pharmaceutical WST.N rise 7.3% to $384.5 premarket 
** West Pharma now expects 2026 adjusted profit per share to be between $8.85 and $9.05, compared with its prior view of $8.40 to $8.75 per share
** Expects its annual sales to be in the range of $3.35 billion to $3.38 billion, up from its previous forecast of $3.295 billion to $3.35 billion
** WST reports Q2 adjusted profit of $2.37 per share, above analysts' estimates of $2.08 per share - LSEG data
** Its quarterly revenue came in at $872.3 million, above analysts' expectations of $838.6 million
** As of last close, stock was up 30.3% YTD 

 (Reporting by Siddhi Mahatole)
 ((siddhi.mahatole@thomsonreuters.com))